ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Grants First of its Kind Indication for Chronic Sleep Disorder Treatment
August 13, 2021The U.S. Food and Drug Administration today approved a new indication for Xywav for idiopathic hypersomnia (IH) in adults. IH is an uncommon chronic sleep disorder that causes people to be excessively sleepy during the day even after a good night's sleep.
Pharma Sources Insight January 2025
